Zhende Medical Co., Ltd. (603301.SS)
CNY 22.69
(-0.26%)
CNY 22.69
(-0.26%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 198.39 Million CNY | -70.82% |
| 2022 | 679.87 Million CNY | 14.1% |
| 2021 | 595.86 Million CNY | -76.63% |
| 2020 | 2.54 Billion CNY | 1524.99% |
| 2019 | 156.89 Million CNY | 20.5% |
| 2018 | 130.2 Million CNY | 6.93% |
| 2017 | 121.76 Million CNY | 46.99% |
| 2016 | 82.84 Million CNY | 4.78% |
| 2015 | 79.05 Million CNY | 263.08% |
| 2014 | 21.77 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 146.35 Million CNY | 66.86% |
| 2024 Q1 | 73.39 Million CNY | 171.87% |
| 2024 Q2 | 87.71 Million CNY | 19.5% |
| 2023 Q3 | 63.15 Million CNY | -30.53% |
| 2023 FY | 198.39 Million CNY | -70.82% |
| 2023 Q1 | 146.46 Million CNY | -35.22% |
| 2023 Q2 | 90.9 Million CNY | -37.93% |
| 2023 Q4 | -102.12 Million CNY | -261.7% |
| 2022 FY | 679.87 Million CNY | 14.1% |
| 2022 Q3 | 183.46 Million CNY | 14.88% |
| 2022 Q4 | 226.08 Million CNY | 23.23% |
| 2022 Q2 | 159.7 Million CNY | 42.75% |
| 2022 Q1 | 111.87 Million CNY | -1.29% |
| 2021 FY | 595.86 Million CNY | -76.63% |
| 2021 Q3 | 104.32 Million CNY | -15.89% |
| 2021 Q4 | 113.33 Million CNY | 8.63% |
| 2021 Q1 | 254.17 Million CNY | -43.73% |
| 2021 Q2 | 124.03 Million CNY | -51.2% |
| 2020 Q4 | 451.69 Million CNY | -59.28% |
| 2020 FY | 2.54 Billion CNY | 1524.99% |
| 2020 Q1 | 85.91 Million CNY | 39.07% |
| 2020 Q2 | 902.65 Million CNY | 950.66% |
| 2020 Q3 | 1.1 Billion CNY | 22.88% |
| 2019 FY | 156.89 Million CNY | 20.5% |
| 2019 Q4 | 61.77 Million CNY | 76.47% |
| 2019 Q3 | 35 Million CNY | 18.71% |
| 2019 Q2 | 29.49 Million CNY | -3.67% |
| 2019 Q1 | 30.61 Million CNY | -31.89% |
| 2018 Q4 | 44.94 Million CNY | 35.58% |
| 2018 FY | 130.2 Million CNY | 6.93% |
| 2018 Q1 | 19.7 Million CNY | -60.48% |
| 2018 Q2 | 32.39 Million CNY | 64.39% |
| 2018 Q3 | 33.15 Million CNY | 2.34% |
| 2017 Q2 | 24.27 Million CNY | 10.19% |
| 2017 Q1 | 22.02 Million CNY | 0.0% |
| 2017 FY | 121.76 Million CNY | 46.99% |
| 2017 Q3 | 25.59 Million CNY | 5.47% |
| 2017 Q4 | 49.87 Million CNY | 94.82% |
| 2016 FY | 82.84 Million CNY | 4.78% |
| 2015 FY | 79.05 Million CNY | 263.08% |
| 2014 FY | 21.77 Million CNY | 0.0% |